ID: ALA3883811

Max Phase: Preclinical

Molecular Formula: C26H34N2O5

Molecular Weight: 454.57

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC[C@H](NC(=O)C(=O)CCCCc1ccc2ccccc2c1)C(=O)NCC(=O)OCC

Standard InChI:  InChI=1S/C26H34N2O5/c1-3-5-13-22(25(31)27-18-24(30)33-4-2)28-26(32)23(29)14-9-6-10-19-15-16-20-11-7-8-12-21(20)17-19/h7-8,11-12,15-17,22H,3-6,9-10,13-14,18H2,1-2H3,(H,27,31)(H,28,32)/t22-/m0/s1

Standard InChI Key:  MTDSEYQDTLDWGW-QFIPXVFZSA-N

Associated Targets(Human)

Phospholipase A2 group V 238 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytosolic phospholipase A2 785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Phospholipase A2 group 1B 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.57Molecular Weight (Monoisotopic): 454.2468AlogP: 3.48#Rotatable Bonds: 14
Polar Surface Area: 101.57Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.93CX Basic pKa: CX LogP: 4.50CX LogD: 4.50
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.26Np Likeness Score: -0.18

References

1. Smyrniotou A, Kokotou MG, Mouchlis VD, Barbayianni E, Kokotos G, Dennis EA, Constantinou-Kokotou V..  (2017)  2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors.,  25  (3): [PMID:28034646] [10.1016/j.bmc.2016.12.007]

Source